Published in Drug Law Weekly, November 14th, 2006
A recent report from the United States notes, "Prior studies have shown both high morbidity and mortality for patients with peripartum cardiomyopathy (PPCM). These studies were small and predated current advances in heart failure treatment."
"We sought to determine the outcomes of women with PPCM in the contemporary era and to determine predictors of poor outcome," wrote Johns Hopkins University researchers A.M. Amos and colleagues. "Patients with PPCM from 1990 to 2003 were identified retrospectively through screening of heart failure clinics and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.